Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Persistence of effect of monthly oral ibandronate on bone resorption in postmenopausal osteoporosis
2004-001750-81Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ibandronic acid in osteoporosis (3 arms), sponsored by Merck & Co. Primary endpoint: Primary. Started Nov 2004; status: completed.
02
Drugs
ibandronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on 2004-001750-81.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001750-81.